XML 71 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 644,588 $ 249,227
Restricted cash 3,907 1,500
Accounts receivable, net 116,430 66,523
Inventory 76,769 57,802
Prepaid and other current assets 13,311 2,945
Total current assets 855,005 377,997
Property, plant and equipment, net 2,361 63
Operating lease right-of-use asset 8,511  
Other long-term assets 1,074 174
Intangible asset, net 15,258 7,480
TOTAL ASSETS 882,209 385,714
Current Liabilities:    
Accounts payable 49,950 37,632
Accrued expenses and other current liabilities 139,826 84,171
Current portion of long-term debt from royalty-bearing instrument 50,130 34,240
Deferred revenue, current 2,342 1,220
Total current liabilities 242,248 157,263
Long-Term Liabilities:    
Long-term debt from royalty-bearing instrument   46,108
Deferred revenue, long-term 18,504 19,490
Long-term operating lease liability 9,443  
Other long-term liabilities 3,751 10,523
Total liabilities 273,946 233,384
Commitments and contingencies (Note 8)
Stockholders’ Equity:    
Series A Convertible Preferred Stock, £0.05 par, unlimited authorized; 289,317,460 shares issued and outstanding as of December 31, 2019 and December 31, 2018 (equivalent to 28,931,746 ordinary shares upon future consolidation and redesignation at a 10:1 ratio) 21,850 21,850
Common stock, £0.50 par, unlimited authorized; 365,014,893 issued, 360,103,901 outstanding as of December 31, 2019; 329,110,863 issued, 325,850,013 outstanding as of December 31, 2018 269,173 246,663
Additional paid-in capital 1,764,317 1,282,762
Treasury stock; 4,910,992 shares as of December 31, 2019; 3,260,850 shares as of December 31, 2018 (35,900) (10,413)
Accumulated deficit (1,411,177) (1,388,532)
Total stockholders’ equity 608,263 152,330
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 882,209 $ 385,714